Biote CorpBTMD
BTMD
About: Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.
Employees: 217
0
Funds holding %
of 7,296 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
5% less funds holding
Funds holding: 94 [Q4 2024] → 89 (-5) [Q1 2025]
5.75% less ownership
Funds ownership: 57.75% [Q4 2024] → 52.0% (-5.75%) [Q1 2025]
13% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 30
17% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 18
22% less capital invested
Capital invested by funds: $117M [Q4 2024] → $90.5M (-$26M) [Q1 2025]
50% less funds holding in top 10
Funds holding in top 10: 2 [Q4 2024] → 1 (-1) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for BTMD.
Financial journalist opinion
Neutral
Business Wire
5 days ago
Biote Names Rich Barrera to Board of Directors
IRVING, Texas--(BUSINESS WIRE)--biote Corp.(NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that its Board of Directors has elected Rich Barrera to the Board, effective immediately. “We are pleased to welcome Rich Barrera to Biote's Board of Directors,” said Marc Beer, Executive Chairman of Biote. “Rich has a distinguished background as an investment professional, founding R.
Neutral
Seeking Alpha
1 month ago
biote Corp. (BTMD) Q1 2025 Earnings Call Transcript
biote Corp. (NASDAQ:BTMD ) Q1 2025 Earnings Call May 7, 2025 5:00 PM ET Company Participants Szymon Serowiecki - Investor Relations Bret Christensen - Chief Executive Officer Bob Peterson - Chief Financial Officer Marc Beer - Executive Chairman Conference Call Participants Kaumil Gajrawala - Jefferies Les Sulewski - Truist Jonna Kim - TD Cowen Jeff Van Sinderen - B. Riley George Kelly - ROTH Capital Partners Operator Hello, and welcome to the biote First Quarter 2025 Earnings Conference Call.
Positive
Zacks Investment Research
1 month ago
Biote Corp. (BTMD) Q1 Earnings and Revenues Surpass Estimates
Biote Corp. (BTMD) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.23 per share a year ago.
Neutral
Business Wire
1 month ago
Biote Reports First Quarter 2025 Financial Results
IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for the first quarter ended March 31, 2025. “Biote's first quarter results benefited from efficiencies related to the vertical integration of our 503B manufacturing facility as well as growth in our dietary supplements business,” said Bret Christensen, Biote Chief Executi.
Neutral
Business Wire
1 month ago
Biote Schedules First Quarter 2025 Financial Results Release and Conference Call
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the Company will provide first quarter financial results on Wednesday, May 7, 2025, after the close of the market. A conference call to discuss the firm's results will be held at 5:00 p.m. ET. the same day. Conference Call Details The conference call may be.
Neutral
Business Wire
2 months ago
Biote Announces Purchase of Shares by Directors and CEO
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”) a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that several members of its Board of Directors, along with CEO Bret Christensen, have made open market purchases of Biote's common stock, acquiring an aggregate of approximately 260,000 shares. Marc Beer, Biote Executive Chairman, said, "These share purchase.
Neutral
Seeking Alpha
3 months ago
biote Corp. (BTMD) Q4 2024 Earnings Call Transcript
biote Corp. (NASDAQ:BTMD ) Q4 2024 Earnings Conference Call March 12, 2025 5:00 PM ET Corporate Participants Szymon Serowiecki - Investor Relations Mark Beard - Executive Chairman Bret Christensen - Chief Executive Officer Bob Peterson - Chief Financial Officer Conference Call Participants Les Sulewski - Truist Securities Jeff Van Sinderen - B. Riley George Kelly - ROTH Capital Partners Alex Fuhrman - Craig-Hallum Capital Group Operator Good day, and welcome to the Biote Fourth Quarter 2024 Earnings Conference Call.
Neutral
Business Wire
3 months ago
Biote Reports Fourth Quarter and Full Year 2024 Financial Results
IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights (All financial result comparisons made are against the prior-year period) Revenue of $49.8 million Procedure revenue of $36.6 million Gross profit margin of 71.8% Net in.
Neutral
Business Wire
3 months ago
Biote Schedules Fourth Quarter and Full Year 2024 Financial Results Release and Conference Call
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the Company will provide fourth quarter and full year financial results on Wednesday, March 12, 2025, after the close of the market. A conference call to discuss the firm's results will be held at 5:00 p.m. ET. the same day. Conference Call Details The conf.
Neutral
Business Wire
4 months ago
Biote Announces CEO Retirement and Succession Plan
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that Terry Weber is retiring as Chief Executive Officer and stepping down from the Company's Board of Directors, effective as of February 1, 2025. She will be transitioning to Strategic Advisor to the Company's Board of Directors. Concurrently, Mr. Bret Chr.
Charts implemented using Lightweight Charts™